Research Nester released a report titled “Non-Small Cell Lung Cancer Treatment Market: Global Demand Analysis & Opportunity Outlook 2029″ which delivers detailed overview of the global non-small cell lung cancer treatment market in terms of market segmentation by treatment type, end-user, and region.
Further, for the in-depth analysis, the report encompasses the industry growth indicators, restraints, supply and demand risk, along with detailed discussion on current and future market trends that are associated with the growth of the market.
The non-small cell lung cancer treatment market is projected to grow with a high CAGR during the forecast period, i.e., 2021-2029 on account of the increasing prevalence of non-small cell lung cancer and rising awareness about the disease. According to World Health Organization, in 2020, there were around 2.21 million new cases and 1.80 million deaths from lung cancer globally.
The market is segmented by treatment type into surgery, radiofrequency ablation, radiation therapy, chemotherapy, targeted therapy, immunotherapy, and others. Among these segments, the targeted therapy segment is anticipated to hold the largest share by the end of 2021 in the non-small cell lung cancer treatment market as a result of the higher rates of adoption of targeted therapy than other available treatments. It is also gaining worldwide recognition for its usage as an adjuvant therapy with chemotherapy.
Request Sample For More Information @ https://www.researchnester.com/sample-request-3024
On the basis of region, the market is segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa, out of which, the non-small cell lung cancer treatment market in the Asia Pacific is projected to grow at the highest CAGR throughout the forecast period. Currently, the market in North America holds the largest share. This can be attributed to the presence of leading healthcare providers in the region, especially in the United States, who are extensively involved in the research and development for innovative non-small cell lung cancer treatment procedures.
Increasing Prevalence of Non-Small Cell Lung Cancer and Rising Awareness about the Disease to Drive Market Growth
According to the American Cancer Society, it is estimated that in 2021, there would be about 235, 760 new cases and about 131,880 deaths from lung cancer in U.S.
Non-small cell lung cancer is the most commonly occurring forms of lung cancer. The increasing prevalence of non-small lung cancer has led to the increase in demand for non-small lung cancer therapeutics. Additionally, the rising awareness about non-small cell lung cancer in recent years is also expected to boost the market growth in upcoming years.
However, the limited treatment options for non-small lung cancer and lack of awareness about the disease in lower economic regions are some of the factors that are estimated to restrain market growth in the near future.
Grab PDF Sample For More Information @ https://www.researchnester.com/sample-request-3024
This report also provides the existing competitive scenario of some of the key players of the global non-small cell lung cancer treatment market which includes company profiling of Genentech, Inc., Celgene Corporation (Bristol Myers Squibb), AstraZeneca plc (LON: AZN), Elli Lilly & Company (NYSE: LLY), Pfizer Inc. (NYSE: PFE), Sanofi (EPA: SAN), Astellas Pharma Inc. (TYO), Novartis AG (SWX: NOVN), Takeda Oncology, and others. The profiling enfolds key information of the companies which encompasses business overview, products and services, key financials and recent news and developments. On the whole, the report depicts detailed overview of the global non-small cell lung cancer treatment market that will help industry consultants, equipment manufacturers, existing players searching for expansion opportunities, new players searching possibilities and other stakeholders to align their market centric strategies according to the ongoing and expected trends in the future.
Read More Similar Press Releases:
Gel Warmers Market
Phototherapy Equipment Market
Vitreoretinal Surgery Devices Market
Anti-Malarial Drugs Market
Cervical Pillows Market
About Research Nester:
Research Nester is a one-stop service provider, leading in strategic market research and consulting with an unbiased and unparalleled approach towards helping global industrial players, conglomerates and executives to make wise decisions for their future investment and expansion by providing them qualitative market insights and strategies while avoiding future uncertainties. We believe in honesty and sheer hard work that we trust is reflected in our work ethics. Our vision is not just limited to gain the trust of our clients but also to be equally respected by our employees and being appreciated by the competitors.
Contact Us:
AJ Daniel
Email: info@researchnester.com
U.S. Phone: +1 646 586 9123
U.K. Phone: +44 203 608 5919
